English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, January 19, 2022
Avance Clinical在2022年生物技術展上宣佈為美國擴張進行重大私募股權投資
아방스 클리니컬 바이오테크 쇼케이스 2022에서 미국에서의 확장을 위한 대규모적인 PE 투자를 발표
Avance Clinical在2022年生物技术展上宣布为美国扩张进行重大私募股权投资
Tuesday, January 18, 2022
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Tuesday, October 19, 2021
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验,研究快速缓解难治性抑郁症以及慢性疼痛疗法
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗,研究快速緩解難治性抑鬱症以及慢性疼痛療法
Thursday, August 12, 2021
아방스 클리니컬, 고객 가치 리더십 부문에서 프로스트&설리번 2021 아시아-태평양 CRO 최고기업상 수상
Wednesday, August 11, 2021
Avance Clinical 荣获 Frost & Sullivan 2021 年亚太地区 CRO 最佳实践奖,以表彰其客户价值领导力
Avance Clinical 榮獲 Frost & Sullivan 2021 年亞太地區 CRO 最佳實踐獎,以表彰其客戶價值領導力

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575